Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald E Rose

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Virology|May 20, 2011
Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052Robert A Fridell, Dike Qiu, Lourdes Valera, et al.
Hepatology Communications|September 12, 2018
Discovery of the Novel Entecavir-Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic AnalysisRonald E Rose, Dennis Hernandez, Paul J Falk, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Molecular basis for increased susceptibility of isolates with atazanavir resistance-conferring substitution I50L to other protease inhibitorsJoseph Yanchunas, David R Langley, Li Tao, et al.
Intervirology|April 7, 2005
Replication-competent chimeric hepatitis C virus subgenomic repliconsJulie A Lemm, Mengping Liu, Ronald E Rose, et al.
Hepatology (Baltimore, Md.)|April 26, 2008
Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistanceCarl J Baldick, Daniel J Tenney, Charles E Mazzucco, et al.
Journal of Hepatology|March 26, 2008
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic responseCarl J Baldick, Betsy J Eggers, Jie Fang, et al.
Journal of Virology|June 1, 2007
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirHerbert E Klei, Kevin Kish, Pin-Fang M Lin, et al.
Journal of Virology|February 3, 2007
Inhibition of hepatitis B virus polymerase by entecavirDavid R Langley, Ann W Walsh, Carl J Baldick, et al.
Hepatology (Baltimore, Md.)|March 13, 2009
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapyDaniel J Tenney, Ronald E Rose, Carl J Baldick, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolatesJie Fang, Michael J Wichroski, Steven M Levine, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Virology|May 20, 2011
Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052Robert A Fridell, Dike Qiu, Lourdes Valera, et al.
Hepatology Communications|September 12, 2018
Discovery of the Novel Entecavir-Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic AnalysisRonald E Rose, Dennis Hernandez, Paul J Falk, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Molecular basis for increased susceptibility of isolates with atazanavir resistance-conferring substitution I50L to other protease inhibitorsJoseph Yanchunas, David R Langley, Li Tao, et al.
Intervirology|April 7, 2005
Replication-competent chimeric hepatitis C virus subgenomic repliconsJulie A Lemm, Mengping Liu, Ronald E Rose, et al.
Hepatology (Baltimore, Md.)|April 26, 2008
Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistanceCarl J Baldick, Daniel J Tenney, Charles E Mazzucco, et al.
Journal of Hepatology|March 26, 2008
Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic responseCarl J Baldick, Betsy J Eggers, Jie Fang, et al.
Journal of Virology|June 1, 2007
X-ray crystal structures of human immunodeficiency virus type 1 protease mutants complexed with atazanavirHerbert E Klei, Kevin Kish, Pin-Fang M Lin, et al.
Journal of Virology|February 3, 2007
Inhibition of hepatitis B virus polymerase by entecavirDavid R Langley, Ann W Walsh, Carl J Baldick, et al.
Hepatology (Baltimore, Md.)|March 13, 2009
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapyDaniel J Tenney, Ronald E Rose, Carl J Baldick, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolatesJie Fang, Michael J Wichroski, Steven M Levine, et al.
Pageof 2